Cochrane Abstracts
Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Early Versus Deferred Standard Androgen Suppression Therapy for Advanced Hormone‐sensitive Prostate Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/Early_versus_deferred_standard_androgen_suppression_therapy_for_advanced_hormone‐sensitive_prostate_cancer.
Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/Early_versus_deferred_standard_androgen_suppression_therapy_for_advanced_hormone‐sensitive_prostate_cancer. Accessed March 19, 2025.
Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/Early_versus_deferred_standard_androgen_suppression_therapy_for_advanced_hormone‐sensitive_prostate_cancer
Early Versus Deferred Standard Androgen Suppression Therapy for Advanced Hormone‐sensitive Prostate Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/Early_versus_deferred_standard_androgen_suppression_therapy_for_advanced_hormone‐sensitive_prostate_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer
ID - 438611
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438611/all/Early_versus_deferred_standard_androgen_suppression_therapy_for_advanced_hormone‐sensitive_prostate_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
